Why Is the Extended Window Controversial and What Happened With the FDA?

September 7, 2021

Ever wonder why the FDA didn't approve the extended time window for tPA after ECASS3? Listen here to understand the discussion.

2 Comments

Tweet Share

RSS

More Entries

Recent
Popular

How do we implement ANNEXXa-I into our Clinical Practice?

November 30, 2023

For acute care physicians, anticoagulated patients presenting with intracranial hemorrhage (ICH) is an incredibly challenging clinical scenario. ANNEXa-I is...

0 Comments

Real World Evidence for Management of Severe Bleeding in the Anticoagulated Patient: Impact of Specific Reversal Therapy for Intracranial Hemorrhage and Gastrointestinal Bleeding

July 28, 2023

Real World studies can provide the foundational support necessary for clinicians to effectively manage anticoagulated patients with severe, often...

0 Comments

The Role of Real World Evidence in Driving Clinical Care for Anticoagulated Patients with Life-Threatening Bleeding

March 31, 2023

Experts in Emergency Medicine, Pharmacy, and Neurocritical Care describe the impact of real world evidence on the care of life-threatening bleeding in the...

1 Comments

What Are the Barriers to Success When Implementing Care Pathways for ICH Patients?

July 12, 2022

ICH remains deadly and pathways matter but they aren't always what we need and barriers can be overcome with knowledge.

0 Comments

How Do We Coordinate Care Within Our Hospitals To Improve Outcomes in Hemorrhagic Stroke Patients?

July 5, 2022

Coordinating the necessary care for hemorrhagic patients is complicated- learn the ropes from experts on the UC Stroke Team. "Smoother, faster better" is...

0 Comments

1 2 3 4 5 6 7 8 9 10 Next Last

Stroke Center Designations Are Big Business. Are They More Than That for Patient Care?

June 7, 2022

Stroke center designations are the currency of the realm; but does it matter to patients?

0 Comments

Telemedicine and Acute Stroke Research: What Is the State of the Union?

May 24, 2022

Telemedicine is the future of stroke - is it the future of stroke research?

0 Comments

First Previous 1 2 3 4 5 6 7 8 9 10

STAY CONNECTED

Let’s expand your stroke education network. Follow us on Twitter to get the latest updates about stroke education and stay up-to-date on hot topics in stroke care.

ABOUT THE STROKE JOURNEY

The Stroke Journey is an initiative developed by The National Stroke Education Center (NSEC) that strives to be the premier source of educational information for the diagnosis and treatment of stroke in the United States. NSEC extends the world-class educational expertise of the University of Cincinnati Department of Emergency Medicine and its partners via a variety of traditional and digital resources. NSEC and The Stroke Journey are dedicated to providing outstanding stroke education with timely material that mirrors the real-time changes in the medical education and stroke care landscape.

OUR PARTNERS

The Stroke Journey is a collaboration between the NSEC, EMCREG-International, and MedEd On The Go. Together we are committed to providing high-quality stroke education for healthcare professionals.

Why Is the Extended Window Controversial and What Happened With the FDA?

Archive

Categories

More Entries